Retention in HIV care and predictors of attrition from care among HIV-infected adults receiving combination anti-retroviral therapy in Addis Ababa

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Mekuria, Legese A ^a,b,c   Prins, Jan M ^a   Yalew, Alemayehu W ^c   Sprangers, Mirjam A G ^a   Nieuwkerk, Pythia T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

STAVUDINE; TENOFOVIR; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ETHIOPIA; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SURVIVAL RATE; YOUNG ADULT; CLINICAL TRIAL; COMBINATION DRUG THERAPY; HIV INFECTIONS; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PROCEDURES;

ADULT; ANTI-RETROVIRAL AGENTS; DELIVERY OF HEALTH CARE; DRUG THERAPY, COMBINATION; ETHIOPIA; FEMALE; HIV INFECTIONS; HUMANS; MALE;

EID: 84938675688     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130649     Document Type: Article

References (51)

1. Hogg R, Lima V, Sterne J.A.C., Grabar S, Battegay M, Bonarek M, et al. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in highincome countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372: 293-299. doi: 10. 1016/S0140-6736(08)61113-7 PMID: 18657708
2. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Medicine. March 2005; 6(2):99-106. PMID: 15807715
3. Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. February 2013; 339(6122):961-965. doi: 10.1126/ science.1230413 PMID: 23430655
4. Araya T, Tensou B, Davey G, Berhane Y. Burial surveillance detected significant reduction in HIVrelated deaths in Addis Ababa, Ethiopia. Trop Med Int Health. December 2011; 16(12):1483-1489. doi: 10.1111/j.1365-3156.2011.02867.x PMID: 21859441
5. Deribew A, Deribe K, Reda AA, Tesfaye M, Hailemichael Y, Maja T, et al. Change in quality of life: a follow up study among patients with HIV infection with and without TB in Ethiopia. BMC Public Health. April 2013; 13:408. doi: 10.1186/1471-2458-13-408 PMID: 23627925
6. Reniers G, Araya T, Davey G, Nagelkerke N, Berhane Y, Coutinho R, et al. Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia. AIDS. February 2009; 23(4):511-518. doi: 10.1097/QAD.0b013e32832403d0 PMID: 19169138
7. MoH/FHAPCO [Ethiopia]. Single Point HIV Prevalence Estimate. June 2007. Addis Ababa. Available at: http://www.etharc.org/aidsineth/publications/singlepointprev-2007.pdf. Accessed on 21 Jan 2014.
8. MoH/FHAPCO [Ethiopia]. HIV/AIDS Estimates and Projections in Ethiopia, 2011-2016. Available at: http://fitun.etharc.org/resources/viewcategory/53-hiv-aids-estimates-and-projections. Accessed on: 01 Aug 2014.
9. FMoH/FHAPCO [Ethiopia]. ART scale up in Ethiopia: successes and challenges. January 2009. Addis Ababa, Ethiopia.
10. Assefa Y, Kiflie A, Tesfaye D, Hailemariam D, Kloos H, Edwin W, et al. Outcomes of antiretroviral treatment program in Ethiopia: Retention of patients in care is a major challenge and varies across health facilities. BMC Health Services Research. April 2011; 11:81. doi: 10.1186/1472-6963-11-81 PMID: 21501509
11. Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010 November; 7(4): 234-244. doi: 10.1007/s11904-010-0061-5 PMID: 20820972
12. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. June 2010. 15 Suppl 1: 1-15. doi: 10.1111/j.1365-3156.2010.02508.x PMID: 20586956
13. Assefa Y, Van Damme W, Haile Mariam D, Kloos H. Toward Universal Access to HIV Counseling and Testing and Antiretroviral Treatment in Ethiopia: Looking Beyond HIV Testing and ART Initiation. AIDS PATIENT CARE and STDs. August 2010; 24 (8): 521-525. doi: 10.1089/apc.2009.0286 PMID: 20672972
14. Stricker SM, Fox KA, Baggaley R, Negussie E, de Pee S, Grede N, et al. Retention in care and adherence to ART are critical elements of HIV care interventions. AIDS Behav. October 2014. 18 Suppl 5: S465-475. doi: 10.1007/s10461-013-0598-6 PMID: 24292251
15. Mugavero MJ, Davila JA, Nevin CR, Giordano TP. From Access to Engagement: Measuring Retention in Outpatient HIV Clinical Care. AIDS PATIENT CARE and STDs. October 2010; 24(10):607-613. doi: 10.1089/apc.2010.0086 PMID: 20858055
16. Giordano TP, Gifford AL, White AC Jr, Suarez-Almazor ME, Rabeneck L, Hartman C, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. June 2007; 44(11):1493-1499. PMID: 17479948
17. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. March 2000; 14(4):357-366. PMID: 10770537
18. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. August 2010; 376(9740):532-539. doi: 10.1016/S0140-6736(10) 60936-1 PMID: 20638713
19. Mugavero MJ, Lin HY, Willig JH, Wesfall AO, Ulett KB, Routman JS, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. Jan 2009; 48(2):248-256. doi: 10.1086/595705 PMID: 19072715
20. MoH/FHAPCO [Ethiopia]. Guidelines for the management of opportunistic infections and anti-retroviral treatment in adolescents and adults in Ethiopia. July 2007. Addis Ababa, Ethiopia.
21. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. April 2004; 18(6):887-895. PMID: 15060436
22. Etard JF, Ndiaye I, Thierry-Mieg M, Gueye NF, Gueye PM, Laniece I, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS. May 2006; 20(8):1181-1189. PMID: 16691070
23. Wester CW, Kim S, Bussmann H, Avalos A, Ndwapi N, Peter TF, et al. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr. Nov 2005; 40(3):336-343. PMID: 16249709
24. Weidle PJ, Malamba S, Mwebaze R, Sozi C, Rukundo G, Downing R, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet. Jul 2002; 360(9326):34-40. PMID: 12114039
25. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006 Apr 22; 367(9519):1335-1342. PMID: 16631912
26. Mutasa-Apollo T, Shiraishi RW, Takarinda KC, Dzangare J, Mugurungi O, Murungu J, et al. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's national antiretroviral therapy programme, 2007-2010. PLoS ONE. Jan 2014; 9(1): e86305. doi: 10.1371/journal.pone.0086305 PMID: 24489714
27. Molfino L, Kumar AM, Isaakidis P, Van den Bergh R, Khogali M, Hinderaker SG, et al. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique. Glob Health Action. Apr 2014; 7:23758. doi: 10.3402/gha.v7.23758.eCollection 2014. PMID: 24717189
28. Torian LV, Wiewel EW. Continuity of HIV-Related Medical Care, New York City, 2005-2009: Do Patients Who Initiate Care Stay in Care? AIDS PATIENT CARE and STDs. Feb 2011; 25(2):79-88. doi: 10.1089/apc.2010.0151 PMID: 21284498
29. Centers for Disease Control and Prevention (CDC). Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. Dec 2011; 60(47):1618-1623.
30. Ambrosioni J, Nicolas D, Aguero F, Manzardo C, Miro JM. HIV treatment outcomes in Europe and North America: what can we learn from the differences? Expert Rev Anti Infect Ther. May 2014; 12 (5):523-526. doi: 10.1586/14787210.2014.906900 PMID: 24694073
31. Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 US areas. J Acquir Immune Defic Syndr. May 2012; 60(1):77-82. doi: 10.1097/QAI. 0b013e318249fe90 PMID: 22267016
32. Howe CJ, Cole SR, Napravnik S, Eron JJ. Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007. AIDS Res Hum Retroviruses. Aug 2010; 26(8):875-881. doi: 10.1089/aid.2009.0282 PMID: 20672995
33. Mugavero MJ, Amico KR, Horn T, Thompson MA. The State of Engagement in HIV Care in the United States: From Cascade to Continuum to Control. Clin Infect Dis. Oct 2013; 57(8):1164-1171. doi: 10. 1093/cid/cit420 PMID: 23797289
34. Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, et al. Differences in Human Immunodeficiency Virus care and treatment among subpopulations in the United States. JAMA Intern Med. Jul 2013; 173 (14):1337-1344.
35. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. Mar 2011; 52(6):793-800. doi: 10.1093/cid/ciq243 PMID: 21367734
36. Assefa Y, Alebachew A, Lera M, Lynen L, Wouters E, Van Damme W. Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013. Global Health. May 2014; 10:43. doi: 10.1186/1744-8603-10-43 PMID: 24886686
37. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programs in lower-income countries. Bull World Health Organ. Jul 2008; 86(7):559-567. PMID: 18670668
38. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programs in sub-Saharan Africa. AIDS. Oct 2008, 22:1897-1908. doi: 10.1097/QAD. 0b013e32830007cd PMID: 18784453
39. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. Aug 2006; 296(7):782-793.
40. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. Jun 2005; 5(6):361-373. PMID: 15919622
41. Narita M, Ashkin D, Hollender ES, Pitchenink AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. Jul 1998; 158(1):157-161.
42. Gupta A, Nadkarni G, Yang WT, Chandrasekhar A, Gupte N, Bisson GP, et al. (2011) Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis. PLoS ONE. 6(12): e28691. doi: 10.1371/journal.pone.0028691 PMID: 22220193
43. Tweya H, Feldacker C, Estill J, Jahn A, Ng'ambi W, Ben-Smith A, et al. Are They Really Lost? "True" Status and Reasons for Treatment Discontinuation among HIV Infected Patients on Antiretroviral Therapy Considered Lost to Follow Up in Urban Malawi. PLoS ONE. Sep 2013; 8(9):e75761. doi: 10.1371/ journal.pone. 0075761 PMID: 24086627
44. Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, Mogorosi M, et al. Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts. PLoS ONE. Mar 2008; 3 (3): e1725. doi: 10. 1371/journal.pone.0001725 PMID: 18320045
45. Brown DM, Thorne JE, Foster GL, Duncan JL, Brune LM, Muñana A, et al. Factors affecting attrition in a longitudinal study of patients with AIDS. AIDS Care. October 2006; 18(7):821-829. PMID: 16971294
46. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. June 2013. Geneva. Available at: http://apps.who. int/iris/bitstream/10665/85321/1/9789241505727eng.pdf. Accessed on June 10, 2014.
47. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 revision. Geneva. Available at: http://whqlibdoc.who.int/publications/2010/ 9789241599764eng.pdf. Accessed on June 10, 2014.
48. Lawn SD, Wood R. How can earlier entry of patients into antiretroviral programs in low-income countries be promoted? Clin Infect Dis. 2006 Feb 1; 42(3):431-432; author reply 432-433. PMID: 16392093
49. Harries AD, Zachariah R, Lawn SD, Rosen S. Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. Jun 2010; 15 Suppl 1:70-75. doi: 10.1111/j.1365-3156.2010.02506.x PMID: 20586963
50. Central Statistical Agency [Ethiopia] and ICF International [USA]. 2012. Ethiopia Demographic and Health Survey 2011. Addis Ababa, Ethiopia, and Calverton, Maryland, USA.
51. World Health Organization 2005. Treat 3 million by 2005: Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance, African Region. Geneva. Available at: http://www.who.int/ hiv/pub/guidelines/clinicalstaging.pdf. Accessed on January 12, 2014.